129: Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at Birmingham. (January 2015) - Stevenson, R.; Price, L.; Webster, G.; Brennan, M.; Stange, D.; Wingate, E.; Biard, K.; Ghafoor, Q.